The move to targeted cancer therapies and individualized treatment makes it difficult to design studies that can clear regulatory hurdles. That can slow the development and delivery of promising new treatments. Investigational new drug (IND) application is already a difficult process of data and report gathering.
More and more oncology treatment researchers are looking for ways to smooth the IND path, no matter what the therapeutic is – cell-based, mAbs or small molecule. A new infographic presents a foundational roadmap to navigate a daunting IND application process. You’ll learn how the right partner can streamline and speed IND compliance, compressing go-to-market schedules. Discover how a right partner strategy can:
Thank you for your interest in the infographic! Click below to get your copy.Download Now
Enter the 6 digit code sent to your mobile number
Click on Resend the verification code again